Relx plc (REL)

Sector:

Media

Index:

FTSE 100

3,462.00p
   
  • Change Today:
      18.00p
  • 52 Week High: 3,504.00p
  • 52 Week Low: 2,442.00p
  • Currency: UK Pounds
  • Shares Issued: 1,873.78m
  • Volume: 2,278,641
  • Market Cap: £64,870m
  • RiskGrade: 128

Relx reaffirms full-year outlook

By Michele Maatouk

Date: Wednesday 18 Apr 2018

LONDON (ShareCast) - (ShareCast News) - Relx, formerly Reed Elsevier, reaffirmed its outlook for the full year on Wednesday.
In an update on trading ahead of its annual general meeting, the company said key business trends in the year to date have remained consistent with full-year 2017 across its business.

Relx said it has continued to focus on the organic development of increasingly sophisticated information-based analytics and decision tools that deliver enhanced value to its customers. In addition, it has continued to reshape its portfolio, targeting selective acquisitions that support its organic growth strategies.

Year to date, the group has completed four acquisitions for a total of £668m. It has also completed £325m of the previously announced £700m share buyback, with the remainder to be deployed by year end.

"We are confident that, by continuing to execute on our strategy, we will deliver another year of underlying growth in revenue and in adjusted operating profit, together with growth in adjusted earnings per share on a constant currency basis," the company said.

The simplification of Relx's dual parent holding company structure is in progress and it plans to seek shareholder approval at meetings to be held by the two parent companies in June, with completion expected in the third quarter.

At 1240 BST, the shares were up 0.4% to 1,509p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Reed Elsevier Market Data

Currency UK Pounds
Share Price 3,462.00p
Change Today 18.00p
% Change 0.52 %
52 Week High 3,504.00p
52 Week Low 2,442.00p
Volume 2,278,641
Shares Issued 1,873.78m
Market Cap £64,870m
RiskGrade 128

Reed Elsevier Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
99.21% below the market average99.21% below the market average99.21% below the market average99.21% below the market average99.21% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Price Trend
83.01% above the market average83.01% above the market average83.01% above the market average83.01% above the market average83.01% above the market average
87.23% above the sector average87.23% above the sector average87.23% above the sector average87.23% above the sector average87.23% above the sector average
Income
88.15% below the market average88.15% below the market average88.15% below the market average88.15% below the market average88.15% below the market average
80% below the sector average80% below the sector average80% below the sector average80% below the sector average80% below the sector average
Growth
14.69% below the market average14.69% below the market average14.69% below the market average14.69% below the market average14.69% below the market average
2.33% below the sector average2.33% below the sector average2.33% below the sector average2.33% below the sector average2.33% below the sector average

What The Brokers Say

Strong Buy 4
Buy 6
Neutral 5
Sell 0
Strong Sell 0
Total 15
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Reed Elsevier Dividends

  Latest Previous
  Final Interim
Ex-Div 02-May-24 03-Aug-23
Paid 13-Jun-24 07-Sep-23
Amount 41.80p 17.00p

Trades for 15-May-2024

Time Volume / Share Price
17:15 8,368 @ 3,476.73p
17:15 8,368 @ 3,477.78p
17:15 2,364 @ 3,476.73p
17:15 2,364 @ 3,477.78p
17:15 1,716 @ 3,476.73p

Reed Elsevier Key Personnel

CEO Erik Engstrom
CFO N L Luff
Chair Paul Walker

Top of Page